You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Janssen this week said its CAR T-cell therapy, ciltacabtagene autoleucel (cilta-cel), will undergo accelerated assessment by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) as a
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.